Interview with Walter Medda, Managing Director, Teva Italy
Mr. Medda, Teva’s Italian history is relatively young, could you describe the main facts that describe Teva presence in Italy? Teva Italia was founded in 1996 and is currently the…
Recipharm was established in Sweden in 1995 and has since then grown to become a leading Contract Development and Manufacturing Organisation (CDMO) and is headquartered close to Stockholm.
Today, Recipharm operates 25 facilities in 10 countries (France, Germany, India, Italy, Israel, Portugal, Spain, Sweden, USA and the UK) covering most of the pharmaceutical dosage forms. Recipharm employs around 4.000 people and is listed on NASDAQ Stockholm.
In October 2014 Recipharm acquired Italian Corvette Group including all the operating companies based in Milan (Biologici Italia Laboratories, Edmond Pharma, Liosintex).
In February 2016 Mitim, located in Brescia, was acquired.
In Italy Recipharm operates four manufacturing facilities, specialized in parenterals of freeze-dried and liquid vials and ampoules, lyophilisation of sterile beta-lactam antibiotics in bulk, filling of beta-lactams powder, APIs synthesis oral solid form, Erdosteine business (API synthesis and finished dosages).
Recipharm has the competence, flexibility and facilities to take on challenging projects which require custom tailored processes. With a broad range of expertise and technologies available, Recipharm offers support and services ranging from development and procurement to full-scale manufacturing, distribution, technology transfer and stability studies. In addition to human pharmaceuticals, Recipharm can also supply medical devices and veterinary products.
Please visit our web site: www.recipharm.com
Mr. Medda, Teva’s Italian history is relatively young, could you describe the main facts that describe Teva presence in Italy? Teva Italia was founded in 1996 and is currently the…
Finderm is the result of a courageous entrepreneurial experience, since you initiated the operations in 1995, in the most challenging times for the Italian pharmaceutical industry. Could you briefly introduce…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
You declared in a recent interview that Zambon Group will always keep complying with the vision of your father Alberto, who has always refused acquisition offers from multinationals- a striking…
You are specialised in Cardiology at Padua University, in Tropical Medicine and Hygiene at London University and in Pharmacology at Modena University, in Communication at Bocconi University in Milan, and…
Ferlito Farmaceutici was established in 1937 and has since then grown to become one of the most renowned pharmaceutical pre-wholesalers in Italy. Which specific values of Ferlito do you think…
After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most of my life,…
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Italfarmaco counts amongst the few players who really sustained the growth of the Italian pharmaceutical industry in the past 10 years. Which specific values would you quote as keys to…
You created Abiogen in 1997, following the acquisition of Istituto Gentili by MSD, in order to maintain your family’s entrepreneurial tradition, keeping building on the legacy of your great-grandfather Commendatore…
Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a broad European Group. Your…
Following the successful result of the “Piano Sanitario Nazionale” 2005 – 2008, could you introduce to ours readers the key priorities and main health policies to be implemented by 2009…
See our Cookie Privacy Policy Here
